Fluorescence spectroscopy as a tool to detect and evaluate glucocorticoid-induced skin atrophy

Lasers in Medical Science

Volumn 27, Issue 5, 2012, Pages 1059-1065

  Lemos, Moyses Costa ^a   Correr, Wagner Rafael ^b   Da Silva De Avó, Lucimar Retto ^a   Germano, Carla Maria Ramos ^a   Kurachi, Cristina ^a,b   Polikarpov, Igor ^a,b   Melo, Débora Gusmão ^a,c  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Departamento de Medicina Área Norte   (Brazil)

Author keywords

Atrophy skin detection; Cutaneous atrophy; Fluorescence spectroscopy; Glucocorticoid induced skin atrophy

Indexed keywords

CLOBETASOL PROPIONATE; EOSIN; GLUCOCORTICOID; HEMATOXYLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; HISTOPATHOLOGY; MALE; NEODYMIUM LASER; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN ATROPHY; SKIN BIOPSY; SPECTROPHOTOMETRY;

ANIMALS; ATROPHY; CLOBETASOL; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; MALE; RATS; RATS, WISTAR; SKIN; SPECTROMETRY, FLUORESCENCE;

EID: 84866742793     PISSN: 02688921     EISSN: 1435604X     Source Type: Journal    
DOI: 10.1007/s10103-011-1045-4     Document Type: Article

References (37)

1. Sulzberger MB, Witten VH (1952) Effect of topically applied compound F in selected dermatoses. J Invest Dermatol 19:101-102. doi:10.1038/jid.1952.14
2. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ (2006) Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 54(1):1-15. doi:10.1016/j.jaad.2005.01.010
3. Schoepe S, Schäcke H, May E, Asadullah K (2006) Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 15(6):406-420. doi:10.1111/j.0906- 6705.2006.00435.x
4. Ahluwalia A (1998) Topical glucocorticoids and the skinmechanisms of action: an update. Mediators Inflamm 7(3):183-193. doi:10.1080/09629359891126
5. Korting HC, Hülsebus E, Kerscher M, Greber R, Schäfer-Korting M (1995) Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblasts. Br J Dermatol 133(1):54-59. doi:10.1111/j.1365-2133.1995.tb02492.x
6. Lange K, Kleuser B, Gysler A, Bader M, Maia C, Scheidereit C, Korting HC, Schäfer-Korting M (2000) Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids. Skin Pharmacol Appl Skin Physiol 13(2):93-103. doi:10.1159/000029913
7. Oikarinen A, Haapasaari KM, Sutinen M, Tasanen K (1998) The molecular basis of glucocorticoid-induced skin atrophy: topical glucocorticoid apparently decreases both collagen synthesis and the corresponding collagen mRNA level in human skin in vivo. Br J Dermatol 139(6):1106-10. doi:10.1046/j.1365-2133.1998. 02646.x
8. Averbeck M, Gebhardt C, Anderegg U, Simon JC (2010) Suppression of hyaluronan synthase 2 expression reflects the atrophogenic potential of glucocorticoids. Exp Dermatol 19(8):757-9. doi:10.1111/j.1600-0625.2010.01099.x
9. Black MM (1969) A modified radiographic method for measuring skin thickness. Br J Dermatol 81(9):661-666. doi:10.1111/j.1365-2133.1969.tb16204.x
10. Marks R, Dykes PJ, Roberts E (1975) The measurement of corticosteroid induced dermal atrophy by a radiological method. Arch Dermatol Res 253(2):93-96. doi:10.1007/BF00582060
11. James MP, Black MM, Sparkes CG (1976) Proceedings: measurement of dermal atrophy induced by topical steroids using a radiographic technique. Br J Dermatol 95(Suppl 14):12. doi:10.1111/j.1365-2133.1976.tb07881.x
12. Marks R (1976) Methods for the assessment of skin atrophogenicity of topical corticosteroids. Dermatologica 152(Suppl 1):117-26. doi:10.1159/ 000257872
13. Snyder DS, Greenberg RA (1977) Radiographic measurement of topical corticosteroid-induced atrophy. J Invest Dermatol 69(3):279-81. doi:10.1111/1523-1747.ep12507493
14. Tan CY, Marks R, Payne P (1981) Comparison of xeroradiographic and ultrasound detection of corticosteroid induced dermal thinning. J Invest Dermatol 76(2):126-128. doi:10.1111/1523-1747.ep12525463
15. Kerscher MJ, Korting HC (1992) Topical glucocorticoids of the nonfluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound. Acta Derm Venereol 72(3):214-216
16. Korting HC (1993) Topical glucocorticoids and thinning of normal skin as to be assessed by ultrasound. Curr Probl Dermatol 21:114-121
17. Lévy J, Gassmüller J, Schröder G, Audring H, Sönnichsen N (1994) Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol 7(4):231-236. doi:10.1159/000211299
18. Kolbe L, Kligman AM, Schreiner V, Stoudemayer T (2001) Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 7(2):73-77. doi:10.1034/j.1600-0846. 2001.70203.x
19. Cossmann M, Welzel J (2006) Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial. Br J Dermatol 155(4):700-706. doi:10.1111/j.1365-2133.2006.07369.x
20. Takema Y, Yorimoto Y, Ohsu H, Osanai O, Kawai M (1997) Agerelated discontinuous changes in the in vivo fluorescence of human facial skin. J Dermatol Sci 15(1):55-58. doi:10.1016/S0923-1811 (97) 00612-9
21. Kollias N, Gillies R, Moran M, Kochevar IE, Anderson RR (1998) Endogenous skin fluorescence includes bands that may serve as quantitative markers of aging and photoaging. J Invest Dermatol 111(5):776-780. doi:10.1046/j.1523-1747. 1998.00377.x
22. Sandby-Moller J, Thieden E, Philipsen PA, Heydenreich J, Wulf HC (2004) Skin autofluorescence as a biological UVR dosimeter. Photodermatol Photoimmunol Photomed 20(1):33-40. doi:10.1111/j.1600-0781.2004.00059.x
23. Gillies R, Zonios G, Anderson RR, Kollias N (2000) Fluorescence excitation spectroscopy provides information about human skin in vivo. J Invest Dermatol 115(4):704-707. doi:10.1046/j.1523-1747.2000.00091.x
24. Na R, Stender IM, Wulf HC (2001) Can autofluorescence demarcate basal cell carcinoma from normal skin? A comparison with protoporphyrin IX fluorescence. Acta Derm Venereol 81(4):246-249. doi:10.1080/00015550152572859
25. Brancaleon L, Durkin AJ, Tu JH, Menaker G, Fallon JD, Kollias N (2001) In vivo fluorescence spectroscopy of nonmelanoma skin cancer. Photochem Photobiol 73(2):178-183. doi:10.1562/0031-8655 (2001) 0730178IVFSON2.0. CO2
26. Panjehpour M, Julius CE, Phan MN, Vo-Dinh T, Overholt S (2002) Laser-induced fluorescence spectroscopy for in vivo diagnosis of non-melanoma skin cancers. Lasers Surg Med 31(5):367-373. doi:10.1002/lsm.10125
27. Drakaki E, Kaselouris E, Makropoulou M, Serafetinides AA, Tsenga A, Stratigos AJ, Katsambas AD, Antoniou C (2009) Laser-induced fluorescence and reflectance spectroscopy for the discrimination of basal cell carcinoma from the surrounding normal skin tissue. Skin Pharmacol Physiol 22(3):158-165. doi:10.1159/000211912
28. Ramanujam N (2000) Fluorescence spectroscopy of neoplastic and non-neoplastic tissues. Neoplasia 2(1-2):89-117. doi:10.1038/sj. neo.7900077
29. Kollias N, Stamatas GN (2002) Optical non-invasive approaches to diagnosis of skin diseases. J Investig Dermatol Symp Proc 7(1):64-75. doi:10.1046/j.1523-1747.2002.19635.x
30. Masters BR, So PT, Gratton E (1997) Multiphoton excitation fluorescence microscopy and spectroscopy of in vivo human skin. Biophys J 72(6):2405-2412. doi:10.1016/S0006-3495 (97) 78886-6
31. Lohmann W, Paul E (1988) In situ detection of melanomas by fluorescence measurements. Naturwissenschaften 75(4):201-202. doi:10.1007/BF00735581
32. Chwirot BW, Chwirot S, Redziñski J, Michniewicz Z (1998) Detection of melanomas by digital imaging of spectrally resolved ultraviolet light-induced autofluorescence of human skin. Eur J Cancer 34(11):1730-1734
33. Bliznakova I, Borisova E, Avramov L (2007) Laser-and light-Induced autofluorescence spectroscopy of human skin in dependence on excitation wavelengths. Acta Phys Pol 112(5):1131-1136
34. Leffell DJ, Stetz ML, Milstone LM, Deckelbaum LI (1988) In vivo fluorescence of human skin. A potential marker of photoaging. Arch Dermatol 124(10):1514-1518
35. Lohmann W, Nilles M, Bödeker RH (1991) In situ differentiation between nevi and malignant melanomas by fluorescence measurements. Naturwissenschaften 78(10):456-457. doi:10.1007/BF01134381
36. Heikal AA (2010) Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies. Biomark Med 4(2):241-263. doi:10.2217/bmm.10.1
37. Bagnato VS, Kurachi C, Castro-e-Silva O (2010) New perspectives for optical techniques in diagnostic and treatment of hepatic diseases. Acta Cir Bras 25(2):214-216. doi:10.1590/S0102-86502010000200016